Darryl Maher
Vermogen: 1 132 $ op 30-06-2026
Vermogen: 1 132 $ op 30-06-2026
Darryl Maher worked at CSL Behring (Australia) Pty Ltd. as Vice President-Research & Development.
Dr. Maher served as President of the Australian Pharmaceutical Physicians Association.
Dr. Maher was an Independent Non-Executive Director at Cynata Therapeutics Ltd. from 2020 to 2026.
Dr. Maher earned a doctorate from the University of Melbourne.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 06-07-2026 | 116.666 ( 0,05% ) | 1 132 $ | 30-06-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| CYNATA THERAPEUTICS LIMITED | Directeur/Bestuurslid | 06-07-2026 |
Australian Pharmaceutical Physicians Association | President | - |
CSL Behring (Australia) Pty Ltd.
CSL Behring (Australia) Pty Ltd. BiotechnologyHealth Technology Engages in R&D and production of biotechnology products | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cynata Therapeutics Ltd.
Cynata Therapeutics Ltd. BiotechnologyHealth Technology Engages in stem cell research and development services | Health Technology |
CSL Behring (Australia) Pty Ltd.
CSL Behring (Australia) Pty Ltd. BiotechnologyHealth Technology Engages in R&D and production of biotechnology products | Health Technology |
Australian Pharmaceutical Physicians Association |
Kies jouw editie
Alle financiële informatie op nationaal niveau